Biosimilars 2020 Year in Review
Fish & Richardson Trademark & Copyright Thoughts
FEBRUARY 4, 2021
In September 2020, Representative Glenn Grothman (R-WI) introduced a new bill, the Biosimilar Insulin Access Act of 2020 (H.R. 2020) , the Federal Circuit reversed the district court’s judgment as a matter of law of no anticipation for claims to methods of treatment using a recombinant polypeptide in light of a native form of the polypeptide.
52 
Let's personalize your content